2024
-
Coeptis Therapeutics’ Dave Mehalick on Making Cell Therapy Universally Accessible
In a recent interview with InvestorNews, Dave Mehalick, Chairman, President, and CEO of Coeptis Therapeutics Holdings, Inc. (NASDAQ: COEP),…
-
Guy Bourassa on the Armor Strength of Scandium Canada
In a recent interview with Tracy Weslosky of InvestorNews, Guy Bourassa, CEO and Director of Scandium Canada Ltd. (TSXV: SCD…
-
André Larente from DIAGNOS on Transforming Optometry and Expanding AI Capabilities
In a recent interview with InvestorNews host Tracy Weslosky, André Larente, President, CEO, and Director of DIAGNOS Inc. (TSXV:…
-
John Passalacqua on First Phosphate Meeting the Demand for Battery-Grade LFP Cathode Active Material
April 25, 2024 — In a recent InvestorNews interview, host Peter Clausi spoke with John Passalacqua, CEO and…
-
Thinking about MP/Lynas? Think about Studebaker-Packard
The last great shaking out of the American car-making industry occurred between 1950 and 1960. Nineteen nameplates were…
-
Dave Mehalick from Coeptis Therapeutics to Host InvestorTalk (04.25.2024)
InvestorNews is pleased to announce an upcoming InvestorTalk scheduled for Thursday, April 25th at 9 AM EST, featuring…